Ligand validation:5TZD

C2E: 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)

C2E is a Ligand Of Interest in 5TZD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5TZD_C2E_C_202	66%	9%	0.126	0.932	2.55	2.04	12	12	1	0	100%	1
5TZD_C2E_J_201	66%	9%	0.133	0.938	2.56	2.04	13	12	1	0	100%	1
5TZD_C2E_C_201	62%	9%	0.127	0.921	2.72	2	14	13	2	0	100%	1
5TZD_C2E_J_202	56%	9%	0.145	0.919	2.71	1.99	14	13	2	0	100%	1
5KHD_C2E_R_201	88%	9%	0.097	0.972	2.72	2	14	13	0	0	100%	1
5TZF_C2E_B_201	83%	5%	0.11	0.97	3.72	1.89	15	15	2	0	100%	1
4OAY_C2E_G_201	78%	15%	0.136	0.98	2.31	1.63	15	11	2	0	100%	1
5TZG_C2E_C_204	69%	4%	0.149	0.966	4.32	1.46	25	11	2	0	100%	1
4RT1_C2E_B_201	99%	19%	0.054	0.982	2.38	1.24	11	7	0	0	100%	1
4URG_C2E_A_1241	97%	18%	0.065	0.983	2.24	1.49	10	10	0	0	100%	1
2RDE_C2E_B_301	97%	46%	0.067	0.983	0.93	1.18	2	6	1	0	100%	1
4RT0_C2E_A_202	97%	15%	0.064	0.978	2.23	1.74	11	13	0	0	100%	1
7B0E_C2E_A_401	96%	40%	0.072	0.984	1.2	1.21	3	4	0	0	100%	0.5

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.